Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mercaptopurine (purinethol) (1 trial)
letrozole (femara) (1 trial)
melatonin (1 trial)
fludeoxyglucose f-18 (1 trial)
fluorouracil (efudex) (1 trial)
leucovorin (1 trial)
nivolumab (opdivo) (1 trial)
oxaliplatin (eloxatin) (1 trial)
oxygen (1 trial)
pembrolizumab (keytruda) (1 trial)
high-selenium yeast (1 trial)
lignans (1 trial)
soybean (1 trial)
Breast Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Fatigue (Phase 3)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Lymphedema (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)
Trials (9 total)
Trial APIs (13 total)